Validation of MMS Test for Cancer Monitoring
Conditions
Colo-rectal Cancer - Stomach Cancer - Melanoma
Conditions: official terms
Colorectal Neoplasms - Stomach Neoplasms
Conditions: Keywords
colo-rectal cancer, stomach cancer, melanoma, MMS test, therapy monitoring
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Case-Only, Time Perspective: Prospective
Overall Status
Recruiting
Summary
The purpose of this study is the validation of MMS test to detect active tumor growth in different cancer types before and after therapy, as well as in the course of therapy and for subsequent relapse control compared to standard methods (clinical examination, imaging, tumor markers). It should be consider whether the MMS test has comparable diagnostic accuracy, and thus can replace more expensive or invasive procedures in future.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- Clinical diagnosis of colo-rectal cancer

- Clinical diagnosis of stomach cancer

- Suspected diagnosis of melanoma

Exclusion Criteria:

- Colitis ulcerosa

- Morbus Crohn

- Cancer in time period two years before

- Cancer therapy in time period two years before
Location
HELIOS Klinikum Berlin-Buch, Klinik für Interdisziplinäre Onkologie
Berlin, Germany
Status: Recruiting
Contact: Peter Reichardt, Dr. med. - +49 30 9401 548 00 - peter.reichardt@helios.kliniken.de
Start Date
May 2014
Completion Date
July 2017
Sponsors
MedInnovation GmbH
Source
MedInnovation GmbH
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page